Nieuws
The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option. The FDA’s ...
The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
heeft goedkeuring ontvangen van de U.S. Food and Drug Administration (FDA) voor zijn Tendyne transcatheter mitralisklep vervangingssysteem (TMVR). Dit apparaat biedt een nieuwe behandeloptie voor ...
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option.
Resultaten die mogelijk niet toegankelijk zijn voor u worden momenteel weergegeven.
Niet-toegankelijke resultaten verbergen